BillionToOne Launches Novel Fetal Antigen NIPT as Part of UNITY Screen™ to Help Streamline Management of Pregnant Patients Who Are Alloimmunized

MENLO PARK, Calif., Sept. 30, 2022 /PRNewswire/ — BillionToOne, Inc., a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, announces the launch of their UNITY fetal antigen single-gene non-invasive prenatal test (sgNIPT), a new…